E2 ModeratePreliminaryPEM unclearObservationalPeer-reviewedReviewed
The Impact of COVID Vaccination on Symptoms of Long COVID: An International Survey of People with Lived Experience of Long COVID.
Strain, William David, Sherwood, Ondine, Banerjee, Amitava et al. · Vaccines · 2022 · DOI
Quick Summary
This survey asked 812 people with long COVID about how COVID-19 vaccination affected their symptoms. Overall, 58% reported feeling better after vaccination, 18% felt worse, and the rest noticed no change. People who received mRNA vaccines (like Pfizer and Moderna) tended to see more improvement than those who received other types of vaccines. However, responses varied greatly from person to person.
Why It Matters
Many people with long COVID—including those with ME/CFS—were concerned that COVID vaccination might worsen their symptoms by overstimulating their immune system. This study provides real-world evidence that vaccination was associated with symptom improvement in most long COVID patients, potentially reducing vaccine hesitancy in this vulnerable population and informing treatment discussions.
Observed Findings
- 57.9% of participants reported symptom improvement following COVID-19 vaccination
- 17.9% of participants reported symptom deterioration after vaccination
- 24.2% of participants reported no change in symptoms
- Participants receiving mRNA vaccines showed larger improvements in symptom severity scores compared to those receiving adenoviral vector vaccines
- Considerable individual variation in vaccine response was observed across the cohort
Inferred Conclusions
- COVID-19 vaccination may provide symptomatic benefit for long COVID patients on average, despite initial concerns about immune stimulation
- mRNA vaccine formulations may offer greater symptomatic improvement than adenoviral vector vaccines in this population
- The individual variability in response suggests that vaccination outcomes in long COVID cannot be predicted at the individual level from population averages
Remaining Questions
- What mechanisms explain why some long COVID patients improve while others deteriorate after vaccination?
- How do vaccine responses in long COVID patients compare to responses in the general population, and what biological factors predict individual outcomes?
What This Study Does Not Prove
This observational survey cannot prove that vaccination caused the symptom improvements observed, as there was no control group and responses may reflect natural symptom fluctuation, placebo effect, or other unmeasured factors. The self-reported nature of the data and selection bias (participants willing to complete surveys) limit generalizability. Individual responses varied substantially, so the average finding does not predict any individual patient's outcome.
Tags
Symptom:Post-Exertional MalaiseCognitive DysfunctionPainFatigue
Phenotype:Infection-TriggeredLong COVID Overlap
Method Flag:PEM Not DefinedNo ControlsExploratory OnlyMixed CohortWeak Case Definition
Metadata
- DOI
- 10.3390/vaccines10050652
- PMID
- 35632408
- Review status
- Editor reviewed
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.